Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · IEX Real-Time Price · USD
4.750
-0.100 (-2.06%)
At close: Jul 19, 2024, 4:30 PM
4.720
-0.030 (-0.63%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Intensity Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for INTS stock has a target of 12, which predicts an increase of 152.63% from the current stock price of 4.75.
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for INTS is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +152.63% | Jul 11, 2024 |
Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +152.63% | May 16, 2024 |
Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +152.63% | Mar 21, 2024 |
Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +152.63% | Nov 14, 2023 |
Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +152.63% | Aug 24, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.43
from -1.38
EPS Next Year
n/a
from -1.43
Revenue Forecast
Revenue | 2024 |
---|---|
High | n/a |
Avg | n/a |
Low | n/a |
Revenue Growth
Revenue Growth | 2024 |
---|---|
High | - |
Avg | - |
Low | - |
EPS Forecast
EPS | 2024 |
---|---|
High | -1.47 |
Avg | -1.43 |
Low | -1.37 |
EPS Growth
EPS Growth | 2024 |
---|---|
High | - |
Avg | - |
Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.